IGF1 and sarcopenia: Circulating IGF-1 levels are lower in sarcopenic subjects than in non-sarcopenic subjects, and its levels are associated with sarcopenia in the elderly as well as fat mass and the prevalence of comorbidities in obese subjects [103,104,105].